Cort
Phoenix Rising Founder
- Messages
- 7,392
I adamantly disagree with removing the FDA ex officio! We deserve and need an FDA interface, albeit a much better one. This joker was unwilling to open his FDA Rolodex to help make introductions to his colleagues but he SHOULD be willing to do so. The FDA is to critical to matters of blood safety, drug approval (I realize it's a touchy matter) and approval of tests such a standardized XMRV test which every knows we need to rattle off the things that come to mind. No person can cover that ground but I've had responsibilities to go find answers and points of contacts on behalf of a larger organization in my professional life so why not the ex-officios? I think it's time for an action item list for members with tracked due dates. Goes with the territory does it not?
But what is he supposed to do? He cannot comment publicly on the FDA's assessments of drug trials. (Of which there are only two for CFS). Blood safety is a temporary issue that would better addressed by having someone from the Blood Working Group - which has been done. I have been to every CFSAC meeting for the past five or six years and he is rarely asked questions and he rarely has much to answer. After watching all that I honestly think its a waste of taxpayer money to have him there. Maybe he fulfills some functions with the committees..I don;t know. Was he asked even one question over the two days of the meeting?